Skip to main content
. 2024 Jun 15;14(6):2934–2945. doi: 10.62347/LJDQ3897

Table 6.

Value of CXCL8, tumor markers and inflammatory factors in clinical staging

Variable Patients at stage III (n=87) Patients at stage I-II (n=62) T/Z P
CEA 4.14 [3.06, 4.83] 3.35 [2.54, 4.48] 1.978 0.048
CXCL8 349.79±93.37 281.02±88.00 4.584 <0.001
CYFRA21-1 5.50 [3.54, 18.22] 3.47 [2.17, 5.86] 3.574 <0.001
hs-CRP 15.79 [11.31, 23.64] 13.12 [9.71, 17.39] 2.157 0.031

Notes: CXCL8: chemokine 8; hs-CRP: high sensitivity C-reactive protein; CEA: carcinoembryonic antigen; CYFRA21-1: cytokeratin 19 fragment.